Hap Trading, LLC Fsd Pharma Inc. Call Options Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$0.78 - $1.1 $8,424 - $11,880	-10,800 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$0.82 - $1.1 $656 - $880	-800 Reduced 6.9%	10,800 $0
Q4 2021 Feb 14, 2022	SELL	$0.96 - $1.63 $13,536 - $22,983	-14,100 Reduced 54.86%	11,600 $1,000
Q3 2021 Nov 10, 2021	BUY	$1.45 - $1.84 $10,585 - $13,432	7,300 Added 39.67%	25,700 $2,000
Q1 2021 May 14, 2021	BUY	$1.65 - $3.87 $30,360 - $71,208	18,400 New	18,400 $3,000

Ticker HUGE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 38,218,100
Market Cap $146M
Description
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.